<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The c-Jun-N-terminal kinase (JNK) pathway has been shown to play an important role in excitotoxic neuronal <z:hpo ids='HP_0011420'>death</z:hpo> and several studies have demonstrated a neuroprotective effect of D-JNKi, a <z:chebi fb="7" ids="16670">peptide</z:chebi> inhibitor of JNK, in various models of <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>We have now investigated the effect of D-JNKi in a model of transient focal <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> (90 min) induced by middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> (MCAo) in adult male rats </plain></SENT>
<SENT sid="2" pm="."><plain>D-JNKi (0.1 mg/kg), significantly decreased the volume of <z:mpath ids='MPATH_124'>infarct</z:mpath>, 3 days after <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>Sensorimotor and <z:hpo ids='HP_0100543'>cognitive deficits</z:hpo> were then evaluated over a period of 6 or 10 days after <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> and <z:mpath ids='MPATH_124'>infarct</z:mpath> volumes were measured after behavioral testing </plain></SENT>
<SENT sid="4" pm="."><plain>In behavioral studies, D-JNKi improved the general state of the animals as demonstrated by the attenuation of body <z:hpo ids='HP_0001824'>weight loss</z:hpo> and improvement in neurological score, as compared with animals receiving the vehicle </plain></SENT>
<SENT sid="5" pm="."><plain>Moreover, D-JNKi decreased sensorimotor deficits in the adhesive removal test and improved cognitive function in the object recognition test </plain></SENT>
<SENT sid="6" pm="."><plain>In contrast, D-JNKi did not significantly affect the <z:mpath ids='MPATH_124'>infarct</z:mpath> volume at day 6 and at day 10 </plain></SENT>
<SENT sid="7" pm="."><plain>This study shows that D-JNKi can improve functional recovery after transient focal <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> in the rat and therefore supports the use of this molecule as a potential therapy for <z:hpo ids='HP_0001297'>stroke</z:hpo> </plain></SENT>
</text></document>